Stuart Therapeutics Raises $11M in Series A Funding

24 Mar, 2021

Stuart Therapeutics Raises $11M in Series A Funding
Photo by Daniele D'Andreti on Unsplash

– Stuart Therapeutics from Stuart, Florida develops peptide therapeutics for ophthalmic diseases.
– The company raised $11m in Series A funding.
– The round was led by InFocus Capital Partners, with participation from the Wisconsin Alumni Research Foundation (WARF), MiMo Capital and BioBrit.
– The proceeds from the round will fund Phase 2 clinical trials for the company’s proprietary reparative therapeutic candidate, ST-100.

Biotechnology Health Care North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: